| Cervical Glandular Neoplasm studied in …STUDIED_INderived200 of 285show all (up to 200) |
|---|
| → studied in | NCT02345265Phase 2 · active not recruiting Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02446600Phase 3 · active not recruiting Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02502266Phase 2/Phase 3 · active not recruiting Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03348631Phase 2 · active not recruiting Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05256225Phase 3 · recruiting Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061977Phase 3 · recruiting Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07504588Phase 2 · recruiting Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05112601Phase 2 · recruiting Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07078838Phase 2 · not yet recruiting Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084780Phase 2 · not yet recruiting Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE) · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05276973Phase 1 · active not recruiting Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05920798Phase 1/Phase 2 · active not recruiting Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07020117Phase 1 · recruiting A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04604613active not recruiting Prediction of Recurrence Among Low Risk Endometrial Cancer Patients · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02598219Phase 3 · completed Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence. · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04575935Phase 3 · recruiting Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101775Phase 2 · active not recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02397083Phase 2 · active not recruiting Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812636early Phase 1 · not yet recruiting Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02257528Phase 2 · active not recruiting Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01617382recruiting Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05950464Phase 1 · recruiting Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796672recruiting Feasibility Study of Blood Biomarker Identification in Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02880007Phase 2 · completed Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01081262Phase 3 · active not recruiting Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02142803Phase 1 · active not recruiting TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02839707Phase 2/Phase 3 · active not recruiting Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03660826Phase 2 · active not recruiting Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07753824Phase 2 · not yet recruiting A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA) · condition mapped PROBABILISTIC · 285 trials mapped (103 active) | — | — | Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04034927Phase 2 · active not recruiting Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05281471Phase 3 · recruiting Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349641Phase 2 · not yet recruiting A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02068794Phase 1/Phase 2 · active not recruiting MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02466971Phase 3 · active not recruiting Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06468215NA · recruiting Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05415709early Phase 1 · active not recruiting Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07769346recruiting The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05231122Phase 2 · recruiting Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978625Phase 2 · active not recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Primary Cutaneous Mucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06543576Phase 1/Phase 2 · recruiting External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05046080recruiting Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06549855NA · recruiting PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04291612recruiting Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06580314Phase 3 · recruiting Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05226507Phase 1 · terminated A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04739800Phase 2 · active not recruiting Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595879Phase 1 · active not recruiting Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914612Phase 3 · active not recruiting Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538897Phase 1/Phase 2 · active not recruiting Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06856499Phase 1 · recruiting Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03120624Phase 1 · active not recruiting VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04092270Phase 1 · active not recruiting A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial High Grade Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04719273Phase 2 · completed Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04622670NA · active not recruiting Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07398313NA · completed Effect of Prehabilitation on Recovery Outcomes in Post-Surgical Cervical Cancer Women · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01116648Phase 1/Phase 2 · active not recruiting Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07693452Phase 2 · recruiting Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03587311Phase 2 · active not recruiting Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04214067Phase 3 · active not recruiting Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07436793Phase 2 · recruiting Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01871571Phase 2 · terminated Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Rectal Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07665684Phase 1/Phase 2 · not yet recruiting Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06213571NA · completed Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Appendix Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05639972Phase 1/Phase 2 · recruiting E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Human Papillomavirus-Related Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05686226Phase 2 · recruiting E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Human Papillomavirus-Related Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07107334Phase 2 · recruiting A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00951496Phase 3 · completed Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730347Phase 2 · recruiting A Study of Lorigerlimab in Participants With Advanced Solid Tumors · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07454642Phase 1 · recruiting AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002968Phase 3 · completed Edrecolomab in Treating Patients With Stage II Colon Cancer · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Colon Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01167712Phase 3 · active not recruiting Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03008408Phase 2 · active not recruiting A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05049538recruiting Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06466382NA · recruiting OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05440760NA · recruiting Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07062016recruiting Molecular and ctDNA Characterization of High-Risk Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial High Grade Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02122185Phase 2 · completed Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07276360Phase 2 · recruiting Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04919629Phase 2 · recruiting APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05500391Phase 2 · recruiting Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Ovarian Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03875820Phase 1 · active not recruiting Phase I Trial of Defactinib and VS-6766. · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06513065Phase 3 · recruiting Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP) · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06689956recruiting Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07226102NA · withdrawn Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07378371NA · not yet recruiting Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05542407Phase 1 · recruiting ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04024917NA · recruiting Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07341360early Phase 1 · recruiting Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328737NA · recruiting One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01048853NA · terminated Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05504252Phase 2 · active not recruiting METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06839378NA · completed Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00565851Phase 3 · active not recruiting Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06690775Phase 2 · recruiting CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03422198Phase 3 · recruiting Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02364713Phase 2 · terminated MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05973487Phase 1 · active not recruiting A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Human Papillomavirus-Related Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03738228Phase 1 · completed Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02111941early Phase 1 · completed Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04049227early Phase 1 · completed Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639074Phase 2 · recruiting Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935934Phase 2 · completed Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04111978Phase 3 · recruiting MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07153952Phase 1/Phase 2 · active not recruiting RT for Adenocarcinoma/Adenosquamous Carcinoma · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03300557Phase 2 · completed Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07141186Phase 2 · not yet recruiting QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03748186Phase 1 · completed Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04458597NA · completed Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus. · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02140021NA · terminated Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07028242not yet recruiting Ultrasound and Histology in AEH and Early EEC Treated Conservatively · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06393751Phase 1/Phase 2 · withdrawn Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | High Grade Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03108131Phase 2 · completed Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors · condition mapped PROBABILISTIC · 285 trials mapped (103 active) | — | — | Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02713386Phase 1/Phase 2 · completed Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01101451Phase 3 · completed Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03201861Phase 3 · recruiting Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Breast Mucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02684227Phase 2 · completed Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04665921Phase 1 · terminated A Study of SGN-STNV in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01652196Phase 2 · completed Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Colon Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01814501Phase 2 · completed Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Colon Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06805864Phase 2 · not yet recruiting Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06800391Phase 2 · recruiting Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06783153Phase 1/Phase 2 · not yet recruiting Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06278857Phase 2 · recruiting SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr) · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02387203Phase 2 · active not recruiting Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05403554Phase 1 · recruiting A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02040142Phase 2 · completed HIPEC for Peritoneal Carcinomatosis · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05215574Phase 1 · active not recruiting Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04913337Phase 1/Phase 2 · unknown Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03677024NA · withdrawn Evaluation of the Efficacy for Sentinel Lymph Node Policy in Intermediate-risk Endometrial Carcinomas · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03648489Phase 2 · completed Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01686126Phase 2 · active not recruiting Improving the Treatment for Women With Early Stage Cancer of the Uterus · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001282Phase 1/Phase 2 · terminated A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02020707Phase 1 · completed Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02164461Phase 1 · completed Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04972682NA · completed [SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01649089NA · unknown Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02132858completed Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Rectal Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05080556Phase 2 · recruiting Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05311618Phase 1 · unknown Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02923739Phase 2 · terminated Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03345784Phase 1 · terminated Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06182644NA · unknown Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05613283active not recruiting Primary Cervical Cancer Screening by Self-sampling HPV Test · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03641287NA · terminated The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05498597Phase 1 · unknown AMT-151 in Patients With Selected Advanced Solid Tumours · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00745134Phase 2 · terminated Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Rectal Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05295589Phase 2 · withdrawn Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03452332Phase 1 · completed Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02221999Phase 2/Phase 3 · active not recruiting Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Breast Mucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02232152Phase 1 · completed CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Colon Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05513183completed Severe Neutropenia After HIPEC Using Mitomycin-C · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05945407NA · recruiting Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01992861terminated MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03824704Phase 2 · terminated A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492778Phase 2 · unknown Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02599116NA · unknown Gastrointestinal Microbiome Study of Appendiceal Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02921269Phase 2 · completed Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01693783Phase 2 · completed Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01414608Phase 3 · completed Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01097746Phase 2 · completed First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03693846Phase 2 · terminated Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Colon Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03834571Phase 2 · withdrawn Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04982146Phase 1 · unknown Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04088786Phase 1 · completed Phase I Trial HIPEC With Nal-irinotecan · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05321329Phase 2 · unknown Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03924245Phase 1 · terminated Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03976973Phase 2 · unknown BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04611139Phase 1 · withdrawn Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02728258Phase 2 · completed Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05210348unknown Clinical Evaluation of Detection of High Risk HPV in Urine · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01285102Phase 1 · terminated Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Colon Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03018249early Phase 1 · completed Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00888615Phase 2 · completed Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00989651Phase 1 · completed Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02853318Phase 2 · completed Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00108745Phase 3 · unknown Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02073500recruiting Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02270606Phase 1 · completed Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Rectal Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04498520Phase 1 · withdrawn Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02682693Phase 2 · completed Denosumab as an add-on Neoadjuvant Treatment (GeparX) · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Breast Mucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02093598Phase 2 · completed POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02283658Phase 2 · completed Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01266460Phase 2 · completed Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01711515Phase 1 · completed Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01583426Phase 3 · completed Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto) · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Breast Mucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01643499Phase 1 · completed Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Colon Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02879513Phase 3 · unknown Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy · condition mapped ALIAS · 285 trials mapped (103 active) | — | — | Breast Mucinous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00478426Phase 2 · completed Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04125225withdrawn What Are the Experiences of Patients With Pseudomyxoma Peritonei? · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00924066Phase 2 · terminated Ixabepilone to Treat Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210298unknown International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Pseudomyxoma Peritonei | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01802320Phase 2 · completed Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Colon Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01504126early Phase 1 · completed Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01074411Phase 1 · completed Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01266447Phase 2 · completed Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00262821Phase 3 · terminated Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00262847Phase 3 · completed Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 285 trials mapped (103 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416455Phase 1/Phase 2 · completed Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00803062Phase 3 · completed Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer · condition mapped CURATED_BROADER · 285 trials mapped (103 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |